澳洋健康收盘下跌1.63%，滚动市盈率114.10倍，总市值32.31亿元

Company Overview - Aoyang Health's closing price on August 12 was 4.22 yuan, down 1.63%, with a rolling PE ratio of 114.10 times and a total market value of 3.231 billion yuan [1] - The company operates in the medical services, pharmaceutical distribution, and biotechnology sectors, with main products including medical services and pharmaceutical logistics [1] - As of March 31, 2025, Aoyang Health had 53,714 shareholders, a decrease of 3,624 from the previous period, with an average holding value of 352,800 yuan and an average holding of 27,600 shares per shareholder [1] Financial Performance - In the first quarter of 2025, Aoyang Health reported revenue of 452 million yuan, a year-on-year decrease of 22.27%, and a net profit of 18.4992 million yuan, down 39.82% year-on-year, with a gross margin of 15.09% [2] - The company's PE ratio (TTM) is 114.10, while the industry average is 48.17 and the industry median is 63.54 [2] Industry Comparison - Aoyang Health ranks 39th in the medical services industry based on PE ratio, which has an average of 48.17 and a median of 63.54 [1] - The company has been recognized in various awards, including being ranked 32nd in the non-public hospital top 100 list and 2nd among county-level non-public hospitals in China [1]